Should we take into account Helicobacter pylori infection in a patient with dyspeptic symptoms?;L'infection par Helicobacter pylori doit-elle être prise en compte chez un malade souffrant de dyspepsie?

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 3 II, 2003, Pages 432-439

  Jian, Raymond ^a   Coffin, Benoit ^b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b HÔPITAL LOUIS MOURIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE;

AGE; BACTERIAL INFECTION; BIOSAFETY; BREATH ANALYSIS; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DYSPEPSIA; EMPIRICISM; ENDOSCOPY; FRANCE; HEALTH CARE POLICY; HELICOBACTER PYLORI; HUMAN; RECURRENT DISEASE; REVIEW;

ADULT; AGE FACTORS; AGED; ANTI-ULCER AGENTS; BREATH TESTS; COST-BENEFIT ANALYSIS; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; ENZYME INHIBITORS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; PATIENT CARE PLANNING; PROTON PUMPS; TREATMENT OUTCOME;

EID: 0037365616     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN. Functional gastroduodenal disorders. Gut 1999;45(Suppl 2):1137-42.
2. Colin-Jones DG, Bloom B, Bodemar G, Crean G, Freston J, Gugler R et al. Management of dyspepsia: report of a working party. Lancet 1988;i:576-9.
3. AGA Technical review: evaluation of dyspepsia. Gastroenterology 1998;114:582-95.
4. Axon A. Management of uninvestigated dyspepsia: review and commentary. Gut 2002;50(Suppl 4):iv51-7.
5. Fennerty MB. Review article: Helicobacter pylori and uninvestigated dyspepsia. Aliment Pharmacol Ther 2002;16(Suppl 1):52-7.
6. Haycox A, Einarson T, Eggleston A. The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999;231(Suppl):38-47.
7. Talley NJ. Dyspepsia: management guidelines for the millennium. Gut 2002;50(Suppl 4):iv72-8.
8. McColl KE. Review article: tackling the "dyspeptic problem". Aliment Pharmacol Ther 2001;15(Suppl 2):10-3.
9. Talley NJ, Holtmann G. Approach to the patient with dyspepsia and related functional gastrointestinal complaints. In: Yamada T et al., eds. Textbook of gastroenterology. Philadelphia: Lippincott Williams and Wilkins, 1999:660-82.
10. Indications à visée diagnostique de l'endoscopie digestive haute en pathologie œso-gastro-duodénale de l'adulte à l'exclusion de l'échoendoscopie et l'entéroscopie. Recommandations pour la pratique clinique. ANAES. Service des recommandations et références professionnelles. Mars 2001 www.anaes.fr.
11. Talley NJ, Quan C. Review article: Helicobacter pylori and nonulcer dyspepsia. Aliment Pharmacol Ther 2002;16(Suppl 1):58-65.
12. Danesh J, Lawrence M, Murphy M, Roberts S, Collins R. Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med 2000;160:1192-8.
13. Parsonnet J, Blaser MJ, Perez-Perez GI, Hargrett-Bean N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology 1992;102:41-6.
14. McColl K, Murray L, El Omar E, Dickson A, El Nujumi A, Wirz A et al. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998;339:1869-74.
15. Blum AL, Talley NJ, O'Morain C, van Zanten SV, Labenz J, Stolte M et al. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 1998;339:1875-81.
16. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ 1999;318:833-7.
17. Talley NJ, Vakil N, Ballard ED, Fennerty MB. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia. N Engl J Med 1999;341:1106-11.
18. Bruley D, V, Flejou JF, Colin R, Zaim M, Meunier A, Bidaut-Mazel C. There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment Pharmacol Ther 2001;15:1177-85.
19. Malfertheiner P. Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit. Eur J Gastroenterol Hepatol 2001;13(Suppl 2):S9-11.
20. Veldhuyzen van Zanten SJ, Talley NJ, Blum AL, Bolling-Sternevald E, Sundin M, Junghard O. Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? Gut 2002;50(Suppl 4):iv26-30.
21. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 2000;321:659-64.
22. Flechter J, McColl KEL. Factors predicting response to acid suppression in H. pylori negative NUD (abstract). Gut 2000;46:A92.
23. Veldhuyzen van Zanten SJ, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996;91:660-73.
24. Coffin B, Jian R. Dyspepsies idiopathique et secondaire. In: Rambaud JC, ed. Traité de Gastroentérologie. Paris: Flamarion Médecine-Sciences, 2000:347-54.
25. Talley NJ. Therapeutic options in nonulcer dyspepsia. J Clin Gastroenterol 2001;32:286-93.
26. Bytzer P, Hansen JM, Havelund T, Malchow-Moller A, Schaffalitzky de Muckadell OB. Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement. Eur J Gastroenterol Hepatol 1996;8:359-63.
27. Axon AT. Chronic dyspepsia: who needs endoscopy? Gastroenterology 1997;112:1376-80.
28. Delaney BC, Wilson S, Roalfe A, Roberts L, Redman V, Wearn A et al. Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care. Lancet 2000;356:1965-9.
29. Moayyedi P, Axon AT. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am J Gastroenterol 1999;94:3122-5.
30. McColl KE, El Nujumi A, Murray L, El Omar E, Gillen D, Dickson A et al. The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients. Gut 1997;40:302-6.
31. Moayyedi P, Feltbower R, Brown J, Mason S, Mason J, Nathan J et al. Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group. Lancet 2000;355:1665-9.
32. Chiba N, Van Zanten SJ, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ 2002;324:1012-6.
33. Lassen AT, Pedersen FM, Bytzer P, Schaffalitzky de Muckadell OB. Helicobacter pylori test-and-eradicate versus prompt endoscopy for management of dyspeptic patients: a randomised trial. Lancet 2000;356:455-60.
34. McColl KE, Murray LS, Gillen D, Walker A, Wirz A, Fletcher J et al. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H. pylori testing alone in the management of dyspepsia. BMJ 2002;324:999-1002.
35. Laheij RJF, Hermsen JT, Horrevorts AM, Rongen RJ, Witteman E, Rossum LGM et al. Empirical treatment followed by a test an treat strategy versus prompt endoscopy or radiography in patients with dyspeptic symptoms, a randomized trial in primary care setting (abstract). Gut 2001;120:A88.
36. Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH. Screening and testing for Helicobacter pylori (test and treat strategy) in dyspepsia reduces the number of endoscopies with similar clinical outcomes as compared to propt endoscopy (abstract). Gut 2001;120:A89.
37. Moayyedi P. Helicobacter pylori test and treat strategy for young dyspeptic patients: new data. Gut 2002;50(Suppl 4):iv47-50.
38. Fergani H, Fardy JM. "Test and treat" strategy for management of uninvestigated dyspepsia: a meta-analysis (abstract). Gastroenterology 2001;120:A89.
39. Delaney BC, Wilson S, Roalfe A, Roberts L, Redman V, Wearn A et al. Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. BMJ 2001;322:898-901.
40. Heaney A, Collins JS, Watson RG, McFarland RJ, Bamford KB, Tham TC. A prospective randomised trial of a "test and treat" policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic. Gut 1999;45:186-90.
41. Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811-6.
42. Ofman JJ, Rabeneck L. The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review. Am J Med 1999;106:335-46.
43. Asante MA, Mendall M, Patel P, Ballam L, Northfield TC. A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia. Eur J Gastroenterol Hepatol 1998;10:983-9.
44. Jones RH. Approaches to uninvestigated dyspepsia. Gut 2002;50(Suppl 4):iv42-6.
45. Conférence de consensus Helicobacter pylori - Révision 1999. Conclusions et recommandations révisées du groupe de travail. Gastroenterol Clin Biol 1999;23:C95-104.
46. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter pylori Study Group. Gut 1997;41:8-13.
47. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
48. Charachon A, Etienney I, Flahault A, Soulé JC. La recherche d'Helicobacter pylori et l'endoscopie œso-gastro-duodénale sont les grands oubliés de la prise en charge initiale des patients dyspeptiques en médecine générale (abstract). Gastroenterol Clin Biol 2002;26:A154.
49. American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 1998;114:579-81.
50. McColl KE. Protagonist: should we eradicate Helicobacter pylori in non-ulcer dyspepsia? Gut 2001;48:759-61.